1. $PCYC vs. $INCY vs. $MDVN vs. $ALKS Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=PCYC|INCY|MDVN|ALKS|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  2. @ACInvestorBlog $MDVN Bearish Indicators Abound.

  3. $PCYC vs. $BMRN vs. $MDVN vs. $ALKS Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=PCYC|BMRN|MDVN|ALKS|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  4. $MDVN eh f it. Bought a starter position 131.8

  5. Barclays Believes MDVN Won’t Stop Here $MDVN http://www.analystratings.com/2015/03/27/barclays-believes-mdvn-wont-stop-here/389371/

  6. RT @OphirGottlieb: Fastest Growing Biotechs: - 1 $PCYC 2 $MDVN 3 $GILD 4 $ALXN 5 $BIIB 13 $CELG Scatter plot: http://lite.capitalmarketlabs.com/cmld3b/xy.php?sector=Pharmaceuticals,+Biotechnology+and+Life+Sciences|&x=Equal+Spaced&y=Revenue+TTM,+1-Year+Growth+%25&minMarketCap=10000&maxMarketCap=1000000&minRevenue=0&maxRevenue=1000000&excludedTickers=VRTX|ENDP|INCY|ABBV|ACT|A u201d

  7. Fastest Growing Biotechs: - 1 $PCYC 2 $MDVN 3 $GILD 4 $ALXN 5 $BIIB 13 $CELG Scatter plot: http://lite.capitalmarketlabs.com/cmld3b/xy.php?sector=Pharmaceuticals,+Biotechnology+and+Life+Sciences|&x=Equal+Spaced&y=Revenue+TTM,+1-Year+Growth+%25&minMarketCap=10000&maxMarketCap=1000000&minRevenue=0&maxRevenue=1000000&excludedTickers=VRTX|ENDP|INCY|ABBV|ACT|A

  8. $MDVN has 4 analyst ratings in the last 7 days and 100% are positive. Median target: $145.5 (10% upside). View here: https://www.flashratings.com/stocks/1564-MDVN?src=stks&t=7

  9. Vetr users have upgraded Medivation Inc to a SELL Rating (2 stars), giving $MDVN a target price of $120.50 https://www.vetr.com/research/NASDAQ:MDVN/ratings

  10. $MDVN this one is tough I d like your input. Given current circumstances, what is a reasonable entry point? I m thinking ~117

  11. Brean Capital Weighs In On Medivation Following Update On Terrain Study $MDVN $ALPMF http://www.talkmarkets.com/content/us-markets/brean-capital-weighs-in-on-medivation-following-update-on-terrain-study?post=61620

  12. $MDVN Congratulations to whomever bought my $115 Calls that expire tomorrow. Well played!

  13. Biotechs in product stage w/ at least 2 Billionaire new buyers: $GILD $CELG $MDVN $NKTR $PGNX $ALXN $MDCO $MNKD $SGEN http://hedgemind.com/stocks/symbol?t=PGNX

  14. Brean Capital Weighs In On Medivation Following Update On Terrain Study $MDVN $ALPMF http://www.talkmarkets.com/content/us-markets/brean-capital-weighs-in-on-medivation-following-update-on-terrain-study?post=61620

  15. $MDVN Bearish Indicators Abound.

  16. $MDVN Cash from Operations is Rising. Chart: http://lite.capitalmarketlabs.com/cmld3b/index.php?shortcode=MDVN&financial_bar=Cash+from+Operations+(TTM+US$+Millions)&financial_line=Cash+from+Operations+(TTM+US$+Millions)&start_date=12/31/2003&end_date=12/31/2014&show_line=false&sk=9c3ed523eab67d1526a0bd6d46aebd35

  17. $MDVN gift for the next ride up

  18. $MDVN might consider adding some ITM June and November calls here

  19. Brean Capital Weighs in on $MDVN Following Update on TERRAIN Study http://www.analystratings.com/2015/03/26/brean-capital-weighs-in-on-medivation-following-update-on-terrain-study/389260/

  20. Analytic Investment holds an allocation of 1.3% in $MDVN in his Focus Growth Investment Portfolio

  21. $MDVN Brean Capital Weighs in on Medivation Inc Following Update on TERRAIN Study http://www.smarteranalyst.com/2015/03/26/brean-capital-weighs-medivation-inc-following-update-terrain-study/

  22. Brean Capital Weighs in on $MDVN Following Update on TERRAIN Study http://blog.tipranks.com/2015/03/brean-capital-weighs-in-on-medivation-following-update-on-terrain-study/

  23. $PCYC vs. $BMRN vs. $ALKS vs. $MDVN Compared Across 9 Critical Measures http://litedev.capitalmarketlabs.com/cmld3b/tt.php?tickers=PCYC|BMRN|ALKS|MDVN|&metrics=Revenue+(TTM+US$+Millions)|Net+Income+(TTM+US$+Millions)|Revenue/Number+of+Employees+(TTM+US$+Millions)|Gross+Margin+%|Net+Income+Margin+%|Research+and+Development+Expense/Operating+Expense|Revenue+TTM,+1-Year+Growth+%|Net+Income+TTM,+1-Year+Growth+%|Price+to+Sales+(at+Quarter+End)

  24. Top 10 most loved biopharma in production stage: $GILD $AMGN $CELG $BIIB $BMRN $ALXN $MDVN $VRTX $ANAC $ACOR; $UTHR http://hedgemind.com/stocks/GILD

  25. $MDVN updated chart with pivot points.